167 related articles for article (PubMed ID: 36198899)
1. Independent association of Lp(a) with platelet reactivity in subjects without statins or antiplatelet agents.
Liu H; Fu D; Luo Y; Peng D
Sci Rep; 2022 Oct; 12(1):16609. PubMed ID: 36198899
[TBL] [Abstract][Full Text] [Related]
2. Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients.
Ling Y; Tang S; Cao Y; Fu C
Dis Markers; 2020; 2020():8818358. PubMed ID: 33029257
[TBL] [Abstract][Full Text] [Related]
3. Statins Therapy Improves Acute Ischemic Stroke in Patients with Cardio-metabolic Disorders Measured by Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): New Focal Point.
Al-Kuraishy HM; Hussien NR; Al-Naimi MS; Al-Gareeb AI; Lugnier C
Neurol India; 2021; 69(6):1637-1644. PubMed ID: 34979662
[TBL] [Abstract][Full Text] [Related]
4. Independent association of PCSK9 with platelet reactivity in subjects without statin or antiplatelet agents.
Wang S; Fu D; Liu H; Peng D
Front Cardiovasc Med; 2022; 9():934914. PubMed ID: 36324757
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
[TBL] [Abstract][Full Text] [Related]
6. Lp-PLA
Yang M; Wang A; Li J; Zhao X; Liu L; Meng X; Jing J; Zhang N; Johnston SC; Wang Y; Wang Y
Neurology; 2020 Jan; 94(2):e181-e189. PubMed ID: 31822574
[TBL] [Abstract][Full Text] [Related]
7. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
8. The effect of statin therapy on lipoprotein associated phospholipase A2 levels.
Albert MA; Glynn RJ; Wolfert RL; Ridker PM
Atherosclerosis; 2005 Sep; 182(1):193-8. PubMed ID: 15982658
[TBL] [Abstract][Full Text] [Related]
9. Influence of lipoprotein-associated phospholipase A
Shen S; Zhong C; Wang A; Han L; Zhu Z; Peng Y; Peng H; Guo D; Zheng X; Xu T; Chen J; Ju Z; Geng D; Zhang Y; He J
Atherosclerosis; 2020 Aug; 306():50-56. PubMed ID: 32688104
[TBL] [Abstract][Full Text] [Related]
10. Increased Lipoprotein-associated phospholipase A2 activity portends an increased risk of resistant hypertension.
Li Z; Liu J; Shen Y; Zeng F; Zheng D
Lipids Health Dis; 2016 Jan; 15():15. PubMed ID: 26801405
[TBL] [Abstract][Full Text] [Related]
11. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein-associated phospholipase A2 is a risk factor for diabetic kidney disease.
Hu Y; Li TT; Zhou W; Lu TT; Li FF; Ding B; Liu BL; Xie XJ; Ma JH
Diabetes Res Clin Pract; 2019 Apr; 150():194-201. PubMed ID: 30904742
[TBL] [Abstract][Full Text] [Related]
13. Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke.
Lin J; Zheng H; Cucchiara BL; Li J; Zhao X; Liang X; Wang C; Li H; Mullen MT; Johnston SC; Wang Y; Wang Y;
Neurology; 2015 Nov; 85(18):1585-91. PubMed ID: 26311748
[TBL] [Abstract][Full Text] [Related]
14. [Lipoprotein-associated phospholipase A2 serum levels in patients from different categories of cardiovascular risk].
Nozadze DN; Sergienko IV; Balakhonova TV; Semenova AE; Vlasik TN; Kukharchuk VV
Kardiologiia; 2014; 54(3):57-63. PubMed ID: 25102750
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet effect of statins is augmented in diabetic rabbits.
Kocić I; Racek-Król B; Wapniarska I; Rusiecka I; Wasilewski R; Bitel M
Pharmacol Rep; 2010; 62(2):410-3. PubMed ID: 20508298
[TBL] [Abstract][Full Text] [Related]
16. Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study.
da Silva IT; Timm Ade S; Damasceno NR
Lipids Health Dis; 2013 Feb; 12():19. PubMed ID: 23413990
[TBL] [Abstract][Full Text] [Related]
17. The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis.
Virani SS; Nambi V
Curr Atheroscler Rep; 2007 Aug; 9(2):97-103. PubMed ID: 17877917
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.
Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA
HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein-associated phospholipase A2.
McConnell JP; Hoefner DM
Clin Lab Med; 2006 Sep; 26(3):679-97, vii. PubMed ID: 16938590
[TBL] [Abstract][Full Text] [Related]
20. Utility of Lp-PLA2 in lipid-lowering therapy.
Racherla S; Arora R
Am J Ther; 2012 Mar; 19(2):115-20. PubMed ID: 20634673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
